naltrexone has been researched along with Body Weight in 138 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 55 (39.86) | 18.7374 |
| 1990's | 33 (23.91) | 18.2507 |
| 2000's | 21 (15.22) | 29.6817 |
| 2010's | 22 (15.94) | 24.3611 |
| 2020's | 7 (5.07) | 2.80 |
| Authors | Studies |
|---|---|
| Barbosa, MP; Carneiro, MG; Costa, JA; de Freitas, MFL; de Souza, IA; de Vasconcelos, DAA; do Nascimento, E; Dos Santos Oliveira, L; Lopes de Souza, S; Matos, RJB; Roberto da Silva, G | 1 |
| McLaughlin, PJ; Purushothaman, I; Sassani, JW; Zagon, IS | 1 |
| Grilo, CM; Gueorguieva, R; Lydecker, JA; Morgan, PT | 1 |
| Berghold, A; Horvath, K; Jeitler, K; Krenn, C; Semlitsch, T; Siebenhofer, A; Winterholer, S | 1 |
| Mills, R; Rege, B; Sadler, BM; Sun, L | 1 |
| Christian, DG; Head, MA; Klockars, A; Levine, AS; Olszewski, PK | 1 |
| Barakat, M; Blavignac, J; Burrows, M; Camacho, F; Christensen, RAG; Gould, E; Kamran, E; Wharton, S; Yin, P | 1 |
| Brooks, EP; Martin-Flores, M; Mitchell, LM; Singh, B; Taylor, L; Walsh, CA | 1 |
| Cottone, P; Mancino, S; Moore, CF; Sabino, V; Schlain, GS | 1 |
| Bont, L; Gharagozlou, MJ; Golara, M; Jamali, A; Mahmoodi, M; Minaei, B; Mirzaei, H; Mokhtari-Azad, T; Ramezani, A; Salimi, V; Shahabi, S; Shokri, F; Tahamtan, A | 1 |
| Fukumura, K; Kubota, R; Wajima, T | 1 |
| Immonen, JA; McLaughlin, PJ; Zagon, IS | 1 |
| Rodgers, RJ; Wright, FL | 2 |
| Bays, H; Burns, C; Fujioka, K; Greenway, F; Gupta, AK; Hollander, P; Klassen, P; Plodkowski, R | 1 |
| Carlezon, WA; Cheng, K; Leitl, MD; Negus, SS; Potter, DN; Rice, KC | 1 |
| Booij, J; de Bruin, K; Goudriaan, AE; la Fleur, SE; van den Brink, W; Zaaijer, ER | 1 |
| Acree, M; Adler, N; Bacchetti, P; Brown, RR; Dallman, M; Daubenmier, J; Epel, ES; Hecht, FM; Laraia, B; Lustig, RH; Mason, AE; Moran, PJ | 1 |
| Hackett, D; Heal, DJ; Hutson, PH; Murray, F; Vickers, SP | 1 |
| Fujioka, K; Gilder, K; Halseth, A; Shan, K; Walsh, B | 1 |
| Alvarado-Bañuelos, M; Barrios De Tomasi, E; Juárez, J | 1 |
| Czachowski, CL; Delory, MJ | 1 |
| Bandelow, B; Gade, K; Häussinger, C | 1 |
| Carroll, MA; McLaughlin, PJ; Sassani, JW; Zagon, IS | 1 |
| Berthoud, HR; Lenard, NR; Zheng, H | 1 |
| Amin, Z; Czarkowski, KA; Epperson, CN; Jatlow, P; Mazure, CM; O'Malley, SS; Toll, B; Wu, R | 1 |
| De Tomasi, EB; Juárez, J | 1 |
| Bray, GA; Ryan, DH | 1 |
| Bello, NT; Liang, NC; Moran, TH | 1 |
| Chabbi, A; Ganesh, CB | 1 |
| Athanacio, J; Clapper, JR; D'Souza, L; Griffin, PS; Parkes, DG; Roth, JD; Wittmer, C | 1 |
| Jarosz, PA; Metzger, BL | 1 |
| McLaughlin, PJ | 2 |
| Corp, ES; Jones, JE | 1 |
| Ingenito, AJ; Wright, RC | 1 |
| Bodnar, RJ; Giraudo, SQ; Grossman, HC; Hadjimarkou, MM; Silva, RM | 1 |
| Chen, RZ; Fong, TM; Huang, RR; MacNeil, DJ; Shen, CP | 1 |
| Arvidsson, J; Chahl, LA; Mizutani, A | 1 |
| Sterious, SN; Walker, EA | 1 |
| Fields, HL; Liang, MT; Mitchell, JM | 1 |
| Nizhnikov, ME; Petrov, ES; Spear, NE; Varlinskaya, EI | 1 |
| Eliana, Bde T; Juárez, J | 1 |
| Cottone, P; Sabino, V; Steardo, L; Zorrilla, EP | 1 |
| Jarosz, PA | 1 |
| Atkinson, RL | 1 |
| DeLander, GE; Portoghese, PS; Takemori, AE | 1 |
| McLaughlin, PJ; Zagon, IS | 7 |
| Nikolarakis, KE; Pfeiffer, A; Pfeiffer, DG | 1 |
| Annitto, W; Gold, MS; Pottash, AL; Sternbach, HA | 1 |
| Smith, AA; Wassef, NM | 1 |
| Luciano, M; Pert, CB; Recant, L; Voyles, NR | 1 |
| Retz, KC; Steele, WJ | 1 |
| Borer, KT; Katz, RJ; Potter, CD | 1 |
| Herman, BH; Holtzman, SG | 1 |
| Balmagiya, T; Gross, E; Marks-Kaufman, R | 1 |
| Christian, MS | 1 |
| Katz, RJ; Manik, CP | 1 |
| Baile, CA; McLaughlin, CL | 1 |
| Anggård, E; Jones, AW; Neri, A | 1 |
| Critcher, EC; Lin, CI; Myers, RD; Patel, J | 1 |
| Aroyewun, OO; Barr, GA | 1 |
| Burks, TF; Schreier, WA | 1 |
| Barnes, CD; Lang, IM; Strahlendorf, HK; Strahlendorf, JC | 1 |
| Bhargava, HN; House, RV; Thomas, PT; Thorat, SN | 1 |
| Misawa, M; Mori, T; Nagase, H; Suzuki, T; Tsuji, M | 1 |
| Conn, CA; Kluger, MJ; Kozak, W | 1 |
| Bodnar, RJ; Bowen, WD; Cole, JL; Leventhal, L; Pasternak, GW | 1 |
| Adams, PB; Bluhm, LD; Campbell, M; Foltz, RL; Gonzalez, NM; Shay, J; Small, AM | 1 |
| Goldberg, G; Mantero-Atienza, E; Mason, BJ; Morgan, RO; Ritvo, EC; Salvato, FR; Welch, B | 1 |
| Kaneto, H; Takahashi, M; Tokuyama, S | 1 |
| Ho, IK; Hoskins, B; Jaw, SP; Makimura, M | 1 |
| Hubbell, CL; McCutcheon, NB | 1 |
| Gottreich, A; Homonnai, ZT; Oppenheim, D; Paz, G; Yavetz, H; Yogev, L | 1 |
| Hammer, RP; Seatriz, JV | 1 |
| Alcaraz, C; Milanés, MV; Vargas, ML | 1 |
| Fantino, M; Wieteska, L | 1 |
| Bacon, JP; Kinzie, J; Luby, ED; Marrazzi, MA | 1 |
| Bridges, RS; Mann, PE; Okimoto, L; Trivedi, A; Zaias, J | 1 |
| Kolta, MG; Ngong, JM; Pierzchala, K; Rutledge, LP; Van Loon, GR | 1 |
| Lang, CM; McLaughlin, PJ; Tobias, SW; Zagon, IS | 1 |
| Billington, CJ; Grace, MK; Kim, EM; Kotz, CM; Levine, AS; Welch, CC | 1 |
| Boedeker, KL; Gardell, LR; Hubbell, CL; Liakos, TM; Reid, LD | 1 |
| Hytrek, SD; McLaughlin, PJ; Tobias, SW; Zagon, IS | 1 |
| Cruz-Madorran, I; Flecknell, PA; Liles, JH; Roughan, J | 1 |
| Boedeker, KL; Cramer, CM; Gardell, LR; Harris, JR; Hubbell, CL; Reid, LD | 1 |
| Biggs, TA; Myers, RD | 1 |
| Pol, O; Puig, MM | 1 |
| Gumułka, SW; Kolaric, S; Makulska-Nowak, HE; Mizerska, K | 1 |
| Bonneau, RH; Lang, CM; McLaughlin, PJ; Zagon, IS; Zalys, R | 1 |
| Bandy, AL; Middaugh, LD | 1 |
| Kagaya, A; Kouhata, S; Nakae, S; Nakata, Y; Yamawaki, S | 1 |
| Barr, GA; Zhu, H | 1 |
| Advis, JP; Boyadjieva, N; Dokur, M; Meadows, GG; Sarkar, DK | 1 |
| Billington, CJ; Briggs, JE; Glass, MJ; Kotz, CM; Levine, AS | 1 |
| Frenk, H; Rosen, JB | 1 |
| Amir, S; Amit, Z; Galina, HZ | 1 |
| Bailey, B; Diaz, J; Paul, L | 1 |
| Braude, MC; Morrison, JM | 1 |
| Di Giulio, AM; Donadoni, ML; Finco, C; Germani, E; Gorio, A; Malosio, ML; Mantegazza, P; Tenconi, B | 1 |
| Misawa, M; Nagase, H; Narita, M; Suzuki, T; Takahashi, Y | 1 |
| Ho, IK; Hoskins, B; Jaw, SP; Makimura, M; Oh, KW | 1 |
| Holtzman, SG; Paronis, CA | 1 |
| Abou-Issa, H; Tejwani, GA | 1 |
| Barr, GA; Capuano, CA; Leibowitz, SF | 1 |
| Fukagawa, Y; Misawa, M; Nagase, H; Suzuki, T | 1 |
| Holtzman, SG | 2 |
| Dousa, MK; Gaumann, DM; Tyce, GM; Yaksh, TL | 1 |
| Horn, PT; Mirkin, BL | 1 |
| Jackson, HC; Kitchen, I | 1 |
| Conti, A; Maestroni, GJ | 1 |
| Beaufrere, B; Chatelain, P; de Parscau, L; François, R; Loeuille, GA; Ythier, H | 1 |
| Appelgate, K; Arthur-Smith, A; Hammock, MK; Herman, BH; Kuehl, K | 1 |
| De Vry, J; Donselaar, I; Van Ree, JM | 1 |
| Bansinath, M; Bhargava, HN; Das, S; Matwyshyn, GA | 1 |
| Herz, A; Millan, MH; Millan, MJ; Reid, LD | 1 |
| Gosnell, BA; Grace, M; Levine, AS | 1 |
| Flood, JF; Morley, JE | 1 |
| Davis, JM; Lamb, DR; Malven, PV; Yim, GK | 1 |
| Carter, MV; Hoerman, WA; Kelsey, JE; Kimball, LD; Radack, LS | 1 |
| Billington, CJ; Brown, DM; Gosnell, BA; Grace, M; Krahn, DD; Levine, AS; Morley, JE | 1 |
| Williams, A | 1 |
| Plendl, J; Reinöhl-Kompa, S; Schmahl, WG | 1 |
| Mucha, RF | 1 |
| Baker, TB; Dahl, JL; Silva, BW; Tiffany, ST | 1 |
| Aceto, MD; Dewey, WL; Portoghese, PS; Takemori, AE | 1 |
| Bracco, EF; Hashim, SA; Kissileff, HR; Maggio, CA; Pfohl, DN; Presta, E; Vasselli, JR | 1 |
| Counts, C; Currey, HS; Malcolm, R; O'Neil, PM; Riddle, FE; Sexauer, JD | 1 |
| France, CP; Woods, JH | 1 |
| Atkinson, RL; Berke, LK; Bibbs, ML; Drake, CR; Kaiser, DL; Williams, FL | 1 |
| Rosella-Dampman, LM; Summy-Long, JY | 1 |
4 review(s) available for naltrexone and Body Weight
| Article | Year |
|---|---|
Long-term effects of weight-reducing drugs in people with hypertension.
Topics: Adult; Anti-Obesity Agents; Appetite Depressants; Bias; Blood Pressure; Body Weight; Bupropion; Diet, Reducing; Drug Combinations; Female; Fructose; Humans; Hypertension; Lactones; Male; Middle Aged; Naltrexone; Orlistat; Phentermine; Piperidines; Pyrazoles; Randomized Controlled Trials as Topic; Safety-Based Drug Withdrawals; Time; Topiramate | 2021 |
Endocrine and metabolic effects of opiate antagonists.
Topics: Adrenocorticotropic Hormone; Animals; Body Weight; Eating; Endocrine Glands; Female; Follicle Stimulating Hormone; Hormones; Humans; Hydrocortisone; Luteinizing Hormone; Male; Mice; Naloxone; Naltrexone; Rats; Vasopressins | 1984 |
Preclinical toxicity studies of naltrexone.
Topics: Administration, Oral; Animals; Body Weight; Colitis; Dogs; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Evaluation, Preclinical; Female; Fertility; Haplorhini; Injections, Subcutaneous; Lethal Dose 50; Male; Mice; Naloxone; Naltrexone; Rats; Reproduction; Rhinitis; Teratogens | 1976 |
[Hypothalamic dysfunction. 2 cases: the contribution of nuclear magnetic resonance, therapeutic trial of naltrexone].
Topics: Body Height; Body Weight; Child, Preschool; Feeding Behavior; Female; Fever; Humans; Hypernatremia; Hypothalamic Diseases; Hypothermia; Magnetic Resonance Imaging; Male; Naltrexone; Obesity; Pituitary Function Tests | 1989 |
13 trial(s) available for naltrexone and Body Weight
| Article | Year |
|---|---|
Naltrexone + Bupropion Combination for the Treatment of Binge-eating Disorder with Obesity: A Randomized, Controlled Pilot Study.
Topics: Adult; Anti-Obesity Agents; Binge-Eating Disorder; Body Weight; Bupropion; Double-Blind Method; Drug Combinations; Female; Humans; Male; Middle Aged; Naltrexone; Obesity; Pilot Projects; Treatment Outcome | 2021 |
Effects of Buprenorphine, Methylnaltrexone, and Their Combination on Gastrointestinal Transit in Healthy New Zealand White Rabbits.
Topics: Analgesics, Opioid; Animals; Body Weight; Buprenorphine; Drug Therapy, Combination; Feces; Gastrointestinal Transit; Laboratory Animal Science; Male; Naltrexone; Narcotic Antagonists; Quaternary Ammonium Compounds; Rabbits | 2017 |
Effects of naltrexone sustained-release/bupropion sustained-release combination therapy on body weight and glycemic parameters in overweight and obese patients with type 2 diabetes.
Topics: Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Blood Glucose; Body Weight; Bupropion; Delayed-Action Preparations; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Obesity; Overweight; Retrospective Studies; Risk Factors; Treatment Outcome; Weight Loss; Young Adult | 2013 |
Acute responses to opioidergic blockade as a biomarker of hedonic eating among obese women enrolled in a mindfulness-based weight loss intervention trial.
Topics: Adult; Behavior, Addictive; Binge-Eating Disorder; Body Mass Index; Body Weight; Bulimia; Eating; Emotions; Female; Humans; Hydrocortisone; Middle Aged; Mindfulness; Motivation; Naltrexone; Narcotic Antagonists; Nausea; Obesity; Opioid Peptides; Receptors, Opioid; Reward; Stress, Psychological; Weight Reduction Programs | 2015 |
Method-of-use study of naltrexone sustained release (SR)/bupropion SR on body weight in individuals with obesity.
Topics: Adolescent; Adult; Body Weight; Bupropion; Delayed-Action Preparations; Dopamine Uptake Inhibitors; Double-Blind Method; Exercise; Feeding Behavior; Female; Humans; Life Style; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Nausea; Obesity; Weight Loss; Young Adult | 2017 |
Exploring the impact of gender and reproductive status on outcomes in a randomized clinical trial of naltrexone augmentation of nicotine patch.
Topics: Administration, Cutaneous; Adult; Aged; Aged, 80 and over; Body Weight; Female; Humans; Interviews as Topic; Male; Medication Adherence; Menstrual Cycle; Middle Aged; Naltrexone; Narcotic Antagonists; Nicotine; Sex Characteristics; Smoking Cessation; Treatment Outcome; Young Adult | 2010 |
Naltrexone plasma levels, clinical response and effect on weight in autistic children.
Topics: Autistic Disorder; Body Weight; Child; Child, Preschool; Double-Blind Method; Female; Humans; Male; Naltrexone; Treatment Outcome | 1994 |
A double-blind, placebo-controlled pilot study to evaluate the efficacy and safety of oral nalmefene HCl for alcohol dependence.
Topics: Alcoholism; Body Weight; Depression; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Humans; Naltrexone; Narcotic Antagonists; Patient Admission; Pilot Projects; Treatment Outcome | 1994 |
Naltrexone use in the treatment of anorexia nervosa and bulimia nervosa.
Topics: Adult; Anorexia Nervosa; Body Weight; Bulimia; Follow-Up Studies; Humans; Naltrexone; Placebo Effect; Time Factors; Treatment Outcome | 1995 |
Effects of acute administration of naltrexone on cardiovascular function, body temperature, body weight and serum concentrations of liver enzymes in autistic children.
Topics: Alanine Transaminase; Aspartate Aminotransferases; Autistic Disorder; Blood Pressure; Body Temperature; Body Weight; Child; Child, Preschool; Electrocardiography; Enzymes; Female; Heart Rate; Hemodynamics; Humans; Male; Naltrexone | 1989 |
Naltrexone and human eating behavior: a dose-ranging inpatient trial in moderately obese men.
Topics: Adult; Basal Metabolism; Body Weight; Clinical Trials as Topic; Drug Administration Schedule; Energy Intake; Feeding Behavior; Humans; Male; Naloxone; Naltrexone; Obesity | 1985 |
A controlled trial of naltrexone in obese humans.
Topics: Adult; Body Weight; Clinical Trials as Topic; Female; Humans; Liver; Male; Middle Aged; Naltrexone; Obesity; Placebos; Random Allocation; Transaminases | 1985 |
Effects of long-term therapy with naltrexone on body weight in obesity.
Topics: Administration, Oral; Adult; Body Weight; Double-Blind Method; Drug Evaluation; Female; Humans; Liver Function Tests; Male; Middle Aged; Naltrexone; Obesity; Random Allocation; Sex Factors | 1985 |
121 other study(ies) available for naltrexone and Body Weight
| Article | Year |
|---|---|
Naltrexone/bupropion modifies weight, food intake, and Drd2 gene expression in rats.
Topics: Animals; Body Weight; Bupropion; Diet, High-Fat; Eating; Gene Expression; Naltrexone; Obesity; Rats; Rats, Wistar; Receptors, Dopamine D2; Tyrosine 3-Monooxygenase | 2022 |
Blockade of OGFr delays the onset and reduces the severity of diabetic ocular surface complications.
Topics: Animals; Blood Glucose; Body Weight; Cornea; Diabetes Complications; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Enkephalin, Methionine; Eye; Male; Naltrexone; Rats, Sprague-Dawley; Receptors, Opioid; Severity of Illness Index; Time Factors | 2021 |
Population Pharmacokinetics of Olanzapine and Samidorphan When Administered in Combination in Healthy Subjects and Patients With Schizophrenia.
Topics: Adolescent; Adult; Age Factors; Aged; Antipsychotic Agents; Body Weight; Cigarette Smoking; Cytochrome P-450 CYP3A; Drug Combinations; Female; Food-Drug Interactions; Humans; Liver Failure; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Olanzapine; Racial Groups; Renal Insufficiency; Rifampin; Schizophrenia; Sex Factors; Young Adult | 2021 |
Effect of combination of peripheral oxytocin and naltrexone at subthreshold doses on food intake, body weight and feeding-related brain gene expression in male rats.
Topics: Animals; Body Weight; Brain; Eating; Gene Expression; Humans; Male; Naltrexone; Oxytocin; Rats | 2021 |
Extended-release naltrexone/bupropion is safe and effective among subjects with type 2 diabetes already taking incretin agents: a post-hoc analysis of the LIGHT trial.
Topics: Aged; Anti-Obesity Agents; Body Weight; Bupropion; Diabetes Mellitus, Type 2; Female; Humans; Hypoglycemic Agents; Incretins; Male; Middle Aged; Naltrexone; Obesity; Randomized Controlled Trials as Topic; Weight Loss | 2021 |
A behavioral and pharmacological characterization of palatable diet alternation in mice.
Topics: Animals; Body Weight; Diet; Energy Intake; Feeding Behavior; Male; Mice; Mice, Inbred C57BL; Naltrexone; Piperazines; Piperidines; Pyrazoles; Rimonabant; Taste | 2017 |
Blocking of opioid receptors in experimental formaline-inactivated respiratory syncytial virus (FI-RSV) immunopathogenesis: from beneficial to harmful impacts.
Topics: Animals; Body Weight; Bronchoalveolar Lavage Fluid; Cytokines; Disease Models, Animal; Immunologic Factors; Lung; Mice, Inbred BALB C; Naltrexone; Narcotic Antagonists; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus Vaccines; T-Lymphocyte Subsets; Viral Load | 2018 |
Population Pharmacokinetics and Exposure-Response Relationships of Naldemedine.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Analgesics, Opioid; Body Weight; Cancer Pain; Chronic Pain; Constipation; Creatinine; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Models, Biological; Naltrexone | 2018 |
Topical naltrexone accelerates full-thickness wound closure in type 1 diabetic rats by stimulating angiogenesis.
Topics: Actins; Administration, Topical; Animals; Blood Glucose; Body Weight; Cell Count; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Fibroblast Growth Factor 2; Hyperglycemia; Inflammation; Male; Mast Cells; Naltrexone; Neovascularization, Physiologic; Rats; Rats, Sprague-Dawley; Skin; Streptozocin; Vascular Endothelial Growth Factor A; Wound Healing | 2013 |
On the behavioural specificity of hypophagia induced in male rats by mCPP, naltrexone, and their combination.
Topics: Animals; Body Weight; Dose-Response Relationship, Drug; Eating; Feeding Behavior; Grooming; Habituation, Psychophysiologic; Male; Motor Activity; Naltrexone; Narcotic Antagonists; Piperazines; Rats; Satiety Response; Serotonin 5-HT1 Receptor Agonists; Serotonin 5-HT2 Receptor Agonists; Time Factors | 2014 |
Behavioural profile of exendin-4/naltrexone dose combinations in male rats during tests of palatable food consumption.
Topics: Animals; Appetite Depressants; Behavior, Animal; Body Weight; Dose-Response Relationship, Drug; Drug Interactions; Eating; Exenatide; Feeding Behavior; Male; Naltrexone; Peptides; Rats; Venoms | 2014 |
Sustained pain-related depression of behavior: effects of intraplantar formalin and complete freund's adjuvant on intracranial self-stimulation (ICSS) and endogenous kappa opioid biomarkers in rats.
Topics: Analgesics, Opioid; Animals; Body Weight; Conditioning, Operant; Disease Models, Animal; Formaldehyde; Freund's Adjuvant; Hyperalgesia; Inhibition, Psychological; Male; Morphine; Naltrexone; Narcotic Antagonists; Pain; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Self Stimulation | 2014 |
Subchronic administration of short-acting naltrexone has no effect on striatal dopamine transporter availability, food intake or body weight gain in rats.
Topics: Animals; Body Weight; Corpus Striatum; Dopamine Plasma Membrane Transport Proteins; Eating; Male; Naltrexone; Narcotic Antagonists; Random Allocation; Rats; Rats, Wistar; Time Factors | 2015 |
Effects of lisdexamfetamine in a rat model of binge-eating.
Topics: Animals; Baclofen; Behavior, Animal; Benzazepines; Benzodiazepines; Body Weight; Bulimia; Disease Models, Animal; Eating; Feeding Behavior; Female; Idazoxan; Lisdexamfetamine Dimesylate; Naltrexone; Olanzapine; Prazosin; Prodrugs; Raclopride; Rats; Rats, Wistar; Rolipram | 2015 |
Changes in the incentive value of food after naltrexone treatment depend on a differential preference for a palatable food in male rats.
Topics: Animals; Body Weight; Choice Behavior; Diet; Dose-Response Relationship, Drug; Eating; Food Preferences; Hypothalamo-Hypophyseal System; Male; Motivation; Naltrexone; Narcotic Antagonists; Pituitary-Adrenal System; Rats; Rats, Wistar; Receptors, Opioid | 2017 |
Acamprosate and naltrexone treatment effects on ethanol and sucrose seeking and intake in ethanol-dependent and nondependent rats.
Topics: Acamprosate; Alcohol Deterrents; Alcohol Drinking; Alcoholism; Animals; Body Weight; Conditioning, Operant; Data Interpretation, Statistical; Male; Naltrexone; Rats; Rats, Long-Evans; Sucrose; Taste; Taurine | 2009 |
Atypical anorexia in a male patient accompanied by strong obsessive-compulsive symptoms successfully treated with naltrexone.
Topics: Adult; Anorexia; Body Weight; Feeding Behavior; Humans; Male; Naltrexone; Narcotic Antagonists; Obsessive Behavior; Obsessive-Compulsive Disorder; Psychiatric Status Rating Scales; Treatment Outcome | 2009 |
Topical application of naltrexone facilitates reepithelialization of the cornea in diabetic rabbits.
Topics: Analysis of Variance; Animals; Blood Glucose; Body Weight; Corneal Diseases; Diabetes Complications; Disease Models, Animal; Enkephalin, Methionine; Epithelium, Corneal; Intraocular Pressure; Male; Naltrexone; Narcotic Antagonists; Rabbits; Regeneration; Time Factors | 2010 |
Chronic suppression of μ-opioid receptor signaling in the nucleus accumbens attenuates development of diet-induced obesity in rats.
Topics: Animals; Body Weight; Dietary Fats; Dietary Sucrose; Food Preferences; Food, Formulated; Male; Naltrexone; Narcotic Antagonists; Nucleus Accumbens; Obesity; Rats; Rats, Sprague-Dawley; Receptors, Opioid, mu | 2010 |
Differential effects of chronic naltrexone treatment on food intake patterns and body weight in rats depend on their food deprivation status.
Topics: Animals; Body Weight; Drinking; Drug Administration Schedule; Eating; Food Deprivation; Male; Naltrexone; Narcotic Antagonists; Rats; Rats, Wistar | 2011 |
Drug treatment of obesity.
Topics: Adolescent; Adult; Anti-Obesity Agents; Antidepressive Agents, Second-Generation; Body Weight; Bupropion; Child; Drug Approval; Drug Combinations; Energy Intake; Exenatide; Female; Fructose; Humans; Hypoglycemic Agents; Islet Amyloid Polypeptide; Lactones; Male; Metformin; Naltrexone; Narcotic Antagonists; Obesity; Orlistat; Patient Compliance; Peptides; Randomized Controlled Trials as Topic; Sympathomimetics; Topiramate; United States; United States Food and Drug Administration; Venoms | 2011 |
Additive feeding inhibitory and aversive effects of naltrexone and exendin-4 combinations.
Topics: Animals; Appetite Depressants; Body Weight; Drug Interactions; Drug Therapy, Combination; Eating; Exenatide; Hypoglycemic Agents; Male; Naltrexone; Obesity; Peptides; Rats; Rats, Sprague-Dawley; Taste; Venoms; Weight Loss | 2013 |
Naltrexone attenuates stress-induced suppression of LH secretion in the pituitary gland in the Cichlid fish Oreochromis mossambicus: evidence for the opioidergic mediation of reproductive stress response.
Topics: Analysis of Variance; Animals; beta-Endorphin; Body Weight; Dose-Response Relationship, Drug; Female; Gonads; Immunohistochemistry; India; Liver; Luteinizing Hormone; Naltrexone; Organ Size; Pituitary Gland; Reproduction; Stress, Physiological; Tilapia | 2013 |
Effects of amylin and bupropion/naltrexone on food intake and body weight are interactive in rodent models.
Topics: Animals; Appetite Depressants; Body Composition; Body Weight; Bupropion; Diet; Drug Interactions; Eating; Gene Expression Regulation; Gene Knockout Techniques; Islet Amyloid Polypeptide; Male; Mice; Naltrexone; Obesity; Rats; Time Factors | 2013 |
The effect of opioid antagonism on food intake behavior and body weight in a biobehavioral model of obese binge eating.
Topics: Animals; Body Weight; Brain; Bulimia; Energy Intake; Feeding Behavior; Hyperphagia; Injections, Intraventricular; Models, Animal; Naltrexone; Narcotic Antagonists; Obesity; Rats; Rats, Zucker; Satiation | 2002 |
Exposure to the opioid antagonist naltrexone throughout gestation alters postnatal heart development.
Topics: Aging; Animals; Body Weight; DNA; Female; Gestational Age; Heart; Litter Size; Male; Myocardium; Naltrexone; Narcotic Antagonists; Opioid Peptides; Organ Size; Pregnancy; Prenatal Exposure Delayed Effects; Proteins; Rats; Rats, Sprague-Dawley; RNA | 2002 |
Effect of naltrexone on food intake and body weight in Syrian hamsters depends on metabolic status.
Topics: Animals; Body Weight; Cricetinae; Drinking; Eating; Female; Male; Mesocricetus; Metabolism; Naltrexone; Narcotic Antagonists; Weight Gain | 2003 |
Blockade of dorsal hippocampal kappa-opioid receptors increases blood pressure in normotensive and isolation-induced hypertensive rats.
Topics: Anesthesia; Animals; Blood Pressure; Body Weight; Heart Rate; Hippocampus; Hypertension; Male; Microinjections; Naltrexone; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Social Isolation; Stress, Psychological | 2003 |
Interrelationships between mu opioid and melanocortin receptors in mediating food intake in rats.
Topics: Animals; beta-Endorphin; Body Weight; Dose-Response Relationship, Drug; Eating; Male; Melanocyte-Stimulating Hormones; Naltrexone; Narcotic Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Melanocortin; Receptors, Opioid, mu | 2003 |
Synergistic effects of cannabinoid inverse agonist AM251 and opioid antagonist nalmefene on food intake in mice.
Topics: Animals; Appetite Regulation; Body Weight; Brain; Cannabinoid Receptor Modulators; Cannabinoids; Dose-Response Relationship, Drug; Drug Synergism; Homeostasis; Male; Mice; Mice, Inbred C57BL; Naltrexone; Narcotic Antagonists; Obesity; Opioid Peptides; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1 | 2004 |
Sensitization to morphine withdrawal in guinea-pigs.
Topics: Amygdala; Analgesics, Opioid; Analysis of Variance; Animals; Behavior, Animal; Body Weight; Brain Chemistry; Cerebral Cortex; Guinea Pigs; Hippocampus; Hypothalamus; Immunohistochemistry; Male; Morphine; Motor Activity; Naltrexone; Proto-Oncogene Proteins c-fos; Rats; Substance Withdrawal Syndrome; Telencephalon; Time Factors | 2005 |
Opioid antagonists differ according to negative intrinsic efficacy in a mouse model of acute dependence.
Topics: Animals; Behavior, Animal; Body Weight; Brain; Diprenorphine; Dose-Response Relationship, Drug; Male; Mice; Morphine; Morphine Dependence; Naloxone; Naltrexone; Narcotic Antagonists; Substance Withdrawal Syndrome; Tremor | 2005 |
A single injection of the kappa opioid antagonist norbinaltorphimine increases ethanol consumption in rats.
Topics: Alcohol Drinking; Animals; Body Weight; Choice Behavior; Conditioning, Psychological; Drinking; Female; Male; Naltrexone; Rats; Rats, Inbred Lew; Receptors, Opioid, kappa; Sex Characteristics | 2005 |
Reinforcing properties of ethanol in neonatal rats: involvement of the opioid system.
Topics: Analysis of Variance; Animals; Animals, Newborn; Behavior, Animal; Body Weight; Bottle Feeding; Central Nervous System Depressants; Cesarean Section; Conditioning, Classical; Ethanol; Female; Male; Naltrexone; Narcotic Antagonists; Narcotics; Rats; Rats, Sprague-Dawley; Reinforcement, Psychology; Sex Factors; Somatostatin | 2006 |
Alcohol consumption is enhanced after naltrexone treatment.
Topics: Alcohol Drinking; Animals; Body Weight; Drinking; Eating; Male; Naltrexone; Narcotic Antagonists; Rats; Rats, Inbred WF; Receptors, Opioid | 2007 |
Opioid-dependent anticipatory negative contrast and binge-like eating in rats with limited access to highly preferred food.
Topics: Adiposity; Animals; Anxiety; Behavior, Animal; Body Weight; Eating; Feeding Behavior; Female; Food; Food Preferences; Ghrelin; Growth Hormone; Leptin; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Rats; Rats, Wistar | 2008 |
The effect of kappa opioid receptor antagonism on energy expenditure in the obese Zucker rat.
Topics: Analysis of Variance; Animals; Body Temperature; Body Weight; Calorimetry, Indirect; Cardiac Catheterization; Disease Models, Animal; Drug Evaluation, Preclinical; Energy Intake; Energy Metabolism; Injections, Intravenous; Male; Motor Activity; Naltrexone; Narcotic Antagonists; Obesity; Rats; Rats, Zucker; Receptors, Opioid, kappa; Respiration; Telemetry | 2007 |
Role of spinal mu opioid receptors in the development of morphine tolerance and dependence.
Topics: Analgesia; Animals; Body Weight; Drug Tolerance; Humans; Male; Morphine; Morphine Dependence; Naltrexone; Rats; Rats, Inbred Strains; Receptors, Opioid; Receptors, Opioid, mu; Spinal Cord | 1984 |
Naltrexone modulates body and brain development in rats: a role for endogenous opioid systems in growth.
Topics: Aging; Animals; Body Weight; Brain; Female; Male; Naloxone; Naltrexone; Organ Size; Rats; Rats, Inbred Strains; Receptors, Opioid | 1984 |
Chronic blockade of opiate receptors: influence on reproduction and body weight in female rats.
Topics: Animals; Body Weight; Estrus; Female; Luteinizing Hormone; Naloxone; Naltrexone; Pregnancy; Rats; Rats, Inbred Strains; Receptors, Opioid; Reproduction | 1984 |
Anorexic effects of naltrexone in man.
Topics: Adolescent; Adult; Anorexia; Body Weight; Feeding and Eating Disorders; Female; Humans; Male; Naloxone; Naltrexone | 1982 |
Inhibition of growth in young mice treated with pentazocine: reversal by naltrexone.
Topics: Animals; Body Weight; Brain; Dose-Response Relationship, Drug; Growth; Liver; Mice; Muscle Proteins; Naloxone; Naltrexone; Pentazocine; Protein Biosynthesis; Receptors, Opioid | 1980 |
Naltrexone reduces weight gain, alters "beta-endorphin", and reduces insulin output from pancreatic islets of genetically obese mice.
Topics: Animals; beta-Endorphin; Body Weight; Endorphins; Insulin; Insulin Secretion; Islets of Langerhans; Mice; Mice, Obese; Naloxone; Naltrexone; Obesity; Pituitary Gland; Receptors, Opioid | 1980 |
Blockade of morphine dependence-related enhancement of secretory protein synthesis in the pons-medulla and striatum-septum by naltrexone.
Topics: Animals; Body Temperature; Body Weight; Brain; Corpus Striatum; Humans; Male; Medulla Oblongata; Morphine Dependence; Naloxone; Naltrexone; Nerve Tissue Proteins; Pons; Rats; Rats, Inbred Strains; Receptors, Opioid | 1983 |
Opiate-receptor blockade reduces voluntary running but not self-stimulation in hamsters.
Topics: Animals; Body Weight; Brain; Cricetinae; Electrodes, Implanted; Female; Hypothalamus; Mesocricetus; Motor Activity; Naltrexone; Receptors, Opioid; Self Stimulation; Time Factors | 1983 |
Naltrexone modulates growth in infant rats.
Topics: Animals; Animals, Newborn; Body Weight; Ear, External; Eye; Female; Growth; Hair; Male; Motor Activity; Naloxone; Naltrexone; Organ Size; Rats; Receptors, Opioid | 1983 |
Repeated administration of naltrexone and diprenorphine decreases food intake and body weight in squirrel monkeys.
Topics: Animals; Body Weight; Diprenorphine; Dose-Response Relationship, Drug; Drinking; Eating; Female; Humans; Male; Morphinans; Naloxone; Naltrexone; Rats; Receptors, Opioid; Receptors, Opioid, kappa; Saimiri; Salivation | 1984 |
Modifications in food intake and energy metabolism in rats as a function of chronic naltrexone infusions.
Topics: Adipose Tissue; Animals; Body Temperature; Body Weight; Carbon Dioxide; Drinking Behavior; Energy Metabolism; Feeding Behavior; Infusions, Parenteral; Male; Naloxone; Naltrexone; Oxygen Consumption; Rats; Rats, Inbred Strains | 1984 |
Reproductive toxicity and teratology evaluations of naltrexone.
Topics: Animals; Body Weight; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Estrus; Female; Fertility; Fetus; Humans; Male; Maternal-Fetal Exchange; Naloxone; Naltrexone; Pregnancy; Rabbits; Rats; Reproduction; Sex Factors; Sexual Behavior, Animal; Teratogens | 1984 |
Stress induced alteration of opiate withdrawal.
Topics: Animals; Body Weight; Humans; Male; Morphine; Naltrexone; Rats; Rats, Inbred Strains; Stress, Physiological; Substance Withdrawal Syndrome | 1984 |
Increased brain size and cellular content in infant rats treated with an opiate antagonist.
Topics: Animals; Animals, Newborn; Body Weight; Brain; Cerebellum; Morphine; Naloxone; Naltrexone; Neuroglia; Organ Size; Rats; Rats, Inbred Strains; Somatosensory Cortex | 1983 |
Nalmefene decreases meal size, food and water intake and weight gain in Zucker rats.
Topics: Animals; Appetite; Appetite Depressants; Body Weight; Drinking; Energy Intake; Female; Male; Naloxone; Naltrexone; Obesity; Rats; Rats, Zucker; Time Factors | 1983 |
Prolonged excretion of morphine in rats during protracted abstinence: lack of effect of naltrexone.
Topics: Animals; Body Weight; Gas Chromatography-Mass Spectrometry; Humans; Male; Morphine; Naloxone; Naltrexone; Rats; Rats, Inbred Strains; Substance Withdrawal Syndrome | 1983 |
Attenuation of alcohol drinking in tetrahydroisoquinoline-treated rats by morphine and naltrexone.
Topics: Alcohol Drinking; Animals; Body Weight; Drinking Behavior; Feeding Behavior; Isoquinolines; Male; Morphine; Naloxone; Naltrexone; Rats; Rats, Inbred Strains; Tetrahydroisoquinolines | 1983 |
Effects of chronic antenatal and postnatal administration of narcotics on naloxone-induced anorexia in preweanling rats.
Topics: Aging; Animals; Animals, Suckling; Body Weight; Drug Interactions; Feeding Behavior; Female; Motor Activity; Naloxone; Naltrexone; Narcotics; Pregnancy; Prenatal Exposure Delayed Effects; Rats | 1983 |
Central regulation of intestinal function: morphine withdrawal diarrhea.
Topics: Animals; Body Weight; Diarrhea; Female; Humans; Intestines; Morphine Dependence; Nalorphine; Naltrexone; Rats; Rats, Inbred Strains; Substance Withdrawal Syndrome | 1982 |
Effects of chronic administration of naltrexone on appetitive behaviors of rats.
Topics: Analgesia; Animals; Appetitive Behavior; Body Weight; Drinking Behavior; Food Deprivation; Kinetics; Naloxone; Naltrexone; Rats; Rats, Inbred Strains | 1981 |
Effects of naltrexone on morphine-induced tolerance and physical dependence and changes in cellular immune function in mice.
Topics: Animals; B-Lymphocytes; Body Weight; Cell Division; Drug Implants; Drug Tolerance; Female; Immunity, Cellular; Killer Cells, Natural; Mice; Morphine; Morphine Dependence; Naltrexone; Substance Withdrawal Syndrome; T-Lymphocytes | 1995 |
Effect of naltrindole on the development of physical dependence on morphine in mice: a behavioral and biochemical study.
Topics: Animals; Behavior, Animal; Body Weight; Male; Mice; Mice, Inbred Strains; Morphine Dependence; Naloxone; Naltrexone; Narcotic Antagonists; Receptors, Opioid; Sodium Chloride; Time Factors | 1995 |
Body temperature, motor activity, and feeding behavior of mice treated with beta-chlornaltrexamine.
Topics: Animals; Behavior, Animal; Body Temperature; Body Weight; Circadian Rhythm; Drinking; Eating; Escherichia coli; Lipopolysaccharides; Male; Mice; Motor Activity; Naltrexone; Narcotic Antagonists; Telemetry | 1995 |
Reductions in body weight following chronic central opioid receptor subtype antagonists during development of dietary obesity in rats.
Topics: Animals; Body Weight; Dietary Fats; Eating; Male; Naloxone; Naltrexone; Narcotic Antagonists; Obesity; Rats; Rats, Sprague-Dawley; Time Factors | 1995 |
Opioid antagonist modulation of rat heart development.
Topics: Aging; Animals; Animals, Newborn; Autoradiography; Body Weight; DNA; Female; Heart; Heart Atria; Heart Ventricles; Hydroxydopamines; Male; Myocardium; Naltrexone; Organ Size; Rats; Rats, Sprague-Dawley; Sympathetic Nervous System; Thymidine | 1994 |
Antinociceptive effect of dihydroetorphine and its tolerance/dependence liability in mice.
Topics: Analgesics; Animals; Body Weight; Drug Tolerance; Etorphine; Male; Mice; Mice, Inbred Strains; Morphine; Motor Activity; Naloxone; Naltrexone; Narcotic Antagonists; Pain Measurement; Substance-Related Disorders | 1993 |
Effects of nor-binaltorphimine on butorphanol dependence.
Topics: Animals; Benzeneacetamides; Body Temperature; Body Weight; Butorphanol; Diarrhea; Down-Regulation; Drug Administration Schedule; Escape Reaction; Male; Naltrexone; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Substance Withdrawal Syndrome; Substance-Related Disorders; Tremor | 1993 |
Opioidergic manipulations affect intake of 3% NaCl in sodium-deficient rats.
Topics: Animals; Body Weight; Drinking Behavior; Furosemide; Male; Morphine; Naltrexone; Narcotics; Rats; Rats, Sprague-Dawley; Sodium; Sodium Chloride, Dietary | 1993 |
Blood luteinizing hormone and prolactin concentrations in response to naltrexone challenge: studies on rats with diabetes induced by different doses of streptozotocin.
Topics: Animals; Blood Glucose; Blood Urea Nitrogen; Body Weight; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Luteinizing Hormone; Male; Naltrexone; Prolactin; Rats; Rats, Wistar; Receptors, Opioid; Streptozocin | 1994 |
Effects of opiates on neuronal development in the rat cerebral cortex.
Topics: Animals; Body Weight; Cerebral Cortex; Female; Male; Morphine; Naltrexone; Narcotic Antagonists; Narcotics; Neurons; Pregnancy; Rats; Rats, Sprague-Dawley; Somatosensory Cortex | 1993 |
Chronic kappa opioid receptor antagonism produces supersensitivity to U-50,488H at the hypothalamo-pituitary-adrenocortical (HPA) axis level.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics; Animals; Body Weight; Corticosterone; Dose-Response Relationship, Drug; Hyperalgesia; Hypothalamo-Hypophyseal System; Male; Naloxone; Naltrexone; Pituitary-Adrenal System; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Sensitivity and Specificity; Sodium Chloride | 1993 |
Evidence for a direct central anorectic effect of tumor-necrosis-factor-alpha in the rat.
Topics: Animals; Appetite; Association Learning; Avoidance Learning; Body Weight; Brain; Conditioning, Classical; Dose-Response Relationship, Drug; Eating; Injections, Intraventricular; Male; Naltrexone; Rats; Recombinant Proteins; Social Environment; Tumor Necrosis Factor-alpha | 1993 |
Inhibitory effects of naltrexone on the induction of parental behavior in juvenile rats.
Topics: Aging; Animals; Body Weight; Female; Growth; Male; Maternal Behavior; Naltrexone; Narcotic Antagonists; Paternal Behavior; Rats; Rats, Sprague-Dawley | 1996 |
Endogenous opioid peptide mediation of hypoalgesic response in long-term diabetic rats.
Topics: Analysis of Variance; Animals; Blood Glucose; Body Weight; Chronic Disease; Diabetes Mellitus, Experimental; Endorphins; Enkephalin, Methionine; Half-Life; Hypoglycemic Agents; Insulin; Male; Naltrexone; Pain Measurement; Pain Threshold; Rats; Rats, Sprague-Dawley | 1996 |
Chronic exposure to the opioid antagonist naltrexone during pregnancy: maternal and offspring effects.
Topics: Animals; Body Weight; Embryonic and Fetal Development; Female; Male; Naltrexone; Narcotic Antagonists; Pregnancy; Pregnancy, Animal; Rats; Rats, Sprague-Dawley; Time Factors | 1997 |
Lactation decreases mRNA levels of opioid peptides in the arcuate nucleus of the rat.
Topics: Animals; Arcuate Nucleus of Hypothalamus; Body Weight; Eating; Estradiol; Female; Lactation; Naltrexone; Narcotic Antagonists; Opioid Peptides; Rats; Rats, Sprague-Dawley; RNA, Messenger | 1997 |
Isradipine and naltrexone in combination with isradipine interact with a period of abstinence to reduce rats' intakes of an alcoholic beverage.
Topics: Alcohol Drinking; Alcoholic Beverages; Animals; Behavior, Animal; Body Weight; Dose-Response Relationship, Drug; Ethanol; Isradipine; Male; Naltrexone; Rats; Rats, Sprague-Dawley; Self Administration | 1997 |
Opioid receptor blockade throughout prenatal life confers long-term insensitivity to morphine and alters mu opioid receptors.
Topics: Analgesics, Opioid; Animals; Body Weight; Female; Male; Morphine; Naltrexone; Narcotic Antagonists; Pain; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Sprague-Dawley; Receptors, Opioid, mu | 1998 |
Influence of oral buprenorphine, oral naltrexone or morphine on the effects of laparotomy in the rat.
Topics: Administration, Oral; Analgesics, Opioid; Animals; Behavior, Animal; Body Weight; Buprenorphine; Drinking; Eating; Laparotomy; Male; Morphine; Naltrexone; Narcotic Antagonists; Pain, Postoperative; Rats; Rats, Wistar; Specific Pathogen-Free Organisms | 1998 |
Isradipine combined with naltrexone persistently reduces the reward-relevant effects of cocaine and alcohol.
Topics: Animals; Body Weight; Calcium Channel Blockers; Central Nervous System Depressants; Cocaine; Conditioning, Operant; Drinking; Drug Interactions; Ethanol; Isradipine; Male; Naltrexone; Narcotic Antagonists; Narcotics; Rats; Rats, Sprague-Dawley; Reward | 1998 |
Naltrexone and amperozide modify chocolate and saccharin drinking in high alcohol-preferring P rats.
Topics: Alcohol Drinking; Animals; Body Weight; Cacao; Dose-Response Relationship, Drug; Eating; Male; Naltrexone; Narcotic Antagonists; Piperazines; Rats; Rats, Inbred Strains; Saccharin; Serotonin Antagonists; Sweetening Agents; Taste | 1998 |
Peripheral effects of opioids in a model of chronic intestinal inflammation in mice.
Topics: Animals; Antidiarrheals; Body Weight; Carbon Monoxide; Enteritis; Gastrointestinal Transit; Jejunum; Loperamide; Male; Mice; Morphine; Naltrexone; Narcotic Antagonists; Narcotics; Receptors, Opioid | 1998 |
Paradoxical effects of intracerebroventricular low-dose opioid antagonists in SHR with chronic pain.
Topics: Analgesia; Animals; Arteries; Blood Pressure; Body Temperature; Body Weight; Brain; Chronic Disease; Hypertension; Injections, Intraventricular; Male; Naloxone; Naltrexone; Narcotic Antagonists; Pain; Pain Threshold; Quaternary Ammonium Compounds; Rats; Rats, Inbred SHR; Rats, Inbred WKY | 1999 |
In vivo effects of chronic treatment with [MET5]-enkephalin on hematological values and natural killer cell activity in athymic mice.
Topics: Animals; Blood Cell Count; Body Weight; Enkephalin, Methionine; Killer Cells, Natural; Leukocyte Count; Male; Mice; Mice, Nude; Naltrexone; Narcotic Antagonists; Organ Size; Spleen | 2000 |
Naltrexone effects on ethanol consumption and response to ethanol conditioned cues in C57BL/6 mice.
Topics: Animals; Body Weight; Conditioning, Psychological; Cues; Dose-Response Relationship, Drug; Eating; Ethanol; Male; Mice; Mice, Inbred C57BL; Motor Activity; Naltrexone; Narcotic Antagonists | 2000 |
Effect of acute lipopolysaccharide administration on (+/-)-1-(2,5-dimethoxy-4-iodophenyl)-2 aminopropane-induced wet dog shake behavior in rats: comparison with body weight change and locomotor activity.
Topics: Amphetamines; Animals; Body Weight; Drug Administration Schedule; Endotoxins; Indomethacin; Lipopolysaccharides; Male; Motor Activity; Naltrexone; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin; Salmonella typhimurium; Serotonin Receptor Agonists; Stereotyped Behavior; Tumor Necrosis Factor-alpha | 2001 |
Inhibition of morphine withdrawal by the NMDA receptor antagonist MK-801 in rat is age-dependent.
Topics: Age Factors; Animals; Body Temperature; Body Weight; Central Nervous System; Dizocilpine Maleate; Dose-Response Relationship, Drug; Drug Administration Routes; Excitatory Amino Acid Antagonists; Male; Morphine; Morphine Dependence; Naltrexone; Narcotic Antagonists; Narcotics; Rats; Rats, Long-Evans; Receptors, N-Methyl-D-Aspartate; Substance Withdrawal Syndrome | 2001 |
Chronic ethanol inhibits NK cell cytolytic activity: role of opioid peptide beta-endorphin.
Topics: Animals; Antibodies; beta-Endorphin; Body Weight; Cells, Cultured; Cytotoxicity Tests, Immunologic; Cytotoxicity, Immunologic; Ethanol; Hypothalamus; Killer Cells, Natural; Lymphocyte Count; Male; Naltrexone; Narcotic Antagonists; Rats; Rats, Inbred F344; Spleen; Tumor Cells, Cultured | 2001 |
Opioid receptor blockade in rat nucleus tractus solitarius alters amygdala dynorphin gene expression.
Topics: Amygdala; Animals; Body Weight; Dynorphins; Eating; Gene Expression; Leptin; Male; Naltrexone; Narcotic Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Opioid; Solitary Nucleus | 2002 |
Suppressant effects of naltrexone on water intake in rats.
Topics: Animals; Body Weight; Depression, Chemical; Drinking Behavior; Female; Naloxone; Naltrexone; Pain; Quinine; Rats; Self Administration; Sensory Thresholds; Time Factors; Water Deprivation | 1979 |
Chronic naltrexone administration reverses the suppressive effect of crowding on body weight gain in rats.
Topics: Animals; Body Weight; Crowding; Male; Naloxone; Naltrexone; Rats; Time Factors | 1979 |
Behavioral effects of chronic narcotic antagonist administration of infant rats.
Topics: Animals; Animals, Newborn; Behavior, Animal; Body Weight; Male; Morphine; Naltrexone; Narcotic Antagonists; Rats; Reaction Time | 1978 |
Perinatal morphine exposure alters peptidergic development in the striatum.
Topics: Animals; Blotting, Northern; Body Weight; Corpus Striatum; Endorphins; Enkephalin, Methionine; Enkephalins; Female; Growth; Immunohistochemistry; In Situ Hybridization; Morphine; Naloxone; Naltrexone; Protein Precursors; Radioimmunoassay; Rats; Rats, Sprague-Dawley; Substance P | 1992 |
Effects of nor-binaltorphimine on the development of analgesic tolerance to and physical dependence on morphine.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesia; Analgesics; Analysis of Variance; Animals; Behavior, Animal; Body Weight; Drug Tolerance; Male; Mice; Morphine; Morphine Dependence; Naltrexone; Pyrrolidines; Rats | 1992 |
Effects of beta-funaltrexamine on butorphanol dependence.
Topics: Animals; Behavior, Animal; Body Temperature; Body Weight; Butorphanol; Dose-Response Relationship, Drug; Injections, Intraventricular; Male; Naloxone; Naltrexone; Narcotic Antagonists; Rats; Rats, Inbred Strains; Reinforcement Schedule; Substance Withdrawal Syndrome; Substance-Related Disorders | 1992 |
Apparent pA2 value of naltrexone is not changed in rats following continuous exposure to morphine or naloxone.
Topics: Analysis of Variance; Animals; Body Weight; Dose-Response Relationship, Drug; Drug Interactions; Fentanyl; Male; Morphine; Naloxone; Naltrexone; Pain Measurement; Rats; Rats, Inbred Strains | 1992 |
Antitumor activity of naltrexone and correlation with steroid hormone receptors.
Topics: Adenocarcinoma; Animals; Body Weight; Endorphins; Female; Mammary Neoplasms, Experimental; Naltrexone; Rats; Receptors, Estrogen; Receptors, Opioid; Receptors, Progesterone | 1991 |
The ontogeny of opioid receptors mediating opiate-induced feeding in rats.
Topics: Aging; Animals; Body Weight; Eating; Female; Male; Morphine; Naltrexone; Narcotics; Rats; Receptors, Opioid | 1990 |
"Paradoxical" analgesia and aggravated morphine dependence induced by opioid antagonists.
Topics: Animals; Body Weight; Indoles; Male; Morphinans; Morphine; Naloxone; Naltrexone; Narcotic Antagonists; Pain Measurement; Rats; Rats, Inbred Strains; Substance Withdrawal Syndrome; Substance-Related Disorders | 1990 |
Phosphodiesterase inhibitors potentiate opiate-antagonist discrimination by morphine-dependent rats.
Topics: 1-Methyl-3-isobutylxanthine; 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Animals; Body Weight; Discrimination, Psychological; Dose-Response Relationship, Drug; Drug Synergism; Male; Morphine; Naltrexone; Narcotic Antagonists; Papaverine; Phosphodiesterase Inhibitors; Rats; Rats, Inbred Strains; Substance Withdrawal Syndrome; Substance-Related Disorders | 1989 |
Adrenal vein catecholamines and met-enkephalin during staged hemorrhage and naltrexone administration in cats.
Topics: Adrenal Glands; Animals; Blood Pressure; Body Weight; Catecholamines; Cats; Chromatography, High Pressure Liquid; Enkephalin, Methionine; Epinephrine; Female; Femoral Artery; Femoral Vein; Hemorrhage; Male; Naltrexone; Norepinephrine; Receptors, Opioid | 1989 |
Lack of effect of the opioid antagonist, naltrexone, on the in situ growth of C-1300, N1E-115 and NS206 murine neuroblastoma tumor cell lines.
Topics: Animals; Body Weight; Chi-Square Distribution; Endorphins; Male; Mice; Mice, Inbred A; Naltrexone; Neoplasm Transplantation; Neoplasms, Experimental; Neuroblastoma; Receptors, Opioid; Tumor Cells, Cultured | 1989 |
Effects of opioid agonists on urine production in neonatal rats.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics; Animals; Animals, Newborn; Benzodiazepines; Body Weight; Female; Male; Morphine; Naltrexone; Narcotics; Phentolamine; Pyrrolidines; Rats; Rats, Inbred Strains; Urodynamics | 1989 |
Beta-endorphin and dynorphin mimic the circadian immunoenhancing and anti-stress effects of melatonin.
Topics: Adjuvants, Immunologic; Animals; beta-Endorphin; Body Weight; Circadian Rhythm; Dynorphins; Erythrocytes; Female; Hemolytic Plaque Technique; Melatonin; Mice; Mice, Inbred BALB C; Naltrexone; Organ Size; Prednisolone; Restraint, Physical; Stress, Psychological; Thymus Gland | 1989 |
Food deprivation and acquisition of intravenous cocaine self-administration in rats: effect of naltrexone and haloperidol.
Topics: Animals; Body Weight; Cocaine; Food Deprivation; Haloperidol; Male; Naltrexone; Rats; Rats, Inbred Strains; Reinforcement, Psychology; Self Administration | 1989 |
Multiple opiate receptors and pharmacological response to morphine in rats maintained on diets differing in protein concentration.
Topics: Analgesics; Animals; Body Temperature; Body Weight; Brain; Dietary Proteins; Drinking; Drug Interactions; Eating; Male; Morphine; Naltrexone; Radioligand Assay; Rats; Rats, Inbred Strains; Receptors, Opioid | 1987 |
The role of the mediobasal arcuate hypothalamus in relation to opioid systems in the control of ingestive behaviour in the rat.
Topics: Animals; Arcuate Nucleus of Hypothalamus; Body Weight; Brain Chemistry; Circadian Rhythm; Dexamethasone; Dynorphins; Endorphins; Enkephalin, Methionine; Feeding Behavior; Food Deprivation; Male; Naltrexone; Rats; Rats, Inbred Strains | 1986 |
Effects of beta-chlornaltrexamine on food intake, body weight and opioid-induced feeding.
Topics: Animals; Body Weight; Dynorphins; Eating; Endorphins; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalin, Leucine; Enkephalins; Male; Naltrexone; Oligopeptides; Rats; Rats, Inbred Strains; Receptors, Opioid | 1987 |
An investigation of tolerance to the actions of leptogenic and anorexigenic drugs in mice.
Topics: Amphetamine; Animals; Appetite Depressants; Body Weight; Calcitonin; Dextroamphetamine; Drug Tolerance; Eating; Fluoxetine; Mice; Morphine; Naltrexone; Neurotransmitter Agents | 1987 |
Opioid modulation of feeding behavior following repeated exposure to forced swimming exercise in male rats.
Topics: Animals; beta-Endorphin; Body Weight; Circadian Rhythm; Deoxyglucose; Endorphins; Feeding Behavior; Insulin; Male; Naltrexone; Physical Exertion; Rats; Rats, Inbred Strains; Swimming; Time Factors | 1985 |
Arcuate nucleus lesions reduce opioid stress-induced analgesia (SIA) and enhance non-opioid SIA in rats.
Topics: Analgesia; Animals; Arcuate Nucleus of Hypothalamus; beta-Endorphin; Biotin; Body Weight; Drinking Behavior; Electroshock; Endorphins; Feeding Behavior; Male; Naltrexone; Pain; Rats; Rats, Inbred Strains; Stereotaxic Techniques; Stress, Psychological; Wheat Germ Agglutinins | 1986 |
Opioid antagonist-induced modulation of cerebral and hippocampal development: histological and morphometric studies.
Topics: Animals; Animals, Suckling; Body Weight; Cell Count; Cerebral Cortex; Endorphins; Female; Hippocampus; Male; Naltrexone; Rats; Rats, Inbred Strains; Receptors, Opioid | 1986 |
beta-Funaltrexamine (beta-FNA) and the regulation of body and brain development in rats.
Topics: Animals; Body Weight; Brain; Cerebellum; Female; Male; Morphine; Naltrexone; Nociceptors; Rats; Rats, Inbred Strains; Receptors, Opioid | 1986 |
Effect of morphine and nalmefene on energy balance in diabetic and non-diabetic rats.
Topics: Animals; Body Weight; Diabetes Mellitus, Experimental; Eating; Energy Metabolism; Male; Morphine; Naltrexone; Rats; Rats, Inbred Strains | 1988 |
Primary care of parenteral substance abusers.
Topics: Acquired Immunodeficiency Syndrome; Administration, Intranasal; Antibodies, Viral; Body Weight; Cocaine; Female; Heart Diseases; Hepatitis; Heroin Dependence; HIV Antibodies; Humans; Injections, Intradermal; Injections, Intravenous; Kidney Diseases; Male; Menstruation Disturbances; Methadone; Naltrexone; Nervous System Diseases; Primary Health Care; Respiratory Tract Diseases; Substance-Related Disorders | 1986 |
Effects of naltrexone in postnatal rats on the recovery of disturbed brain and lymphatic tissues after X-irradiation or ethylnitrosourea treatment in utero.
Topics: Aging; Animals; Body Weight; Brain; Ethylnitrosourea; Female; Male; Naltrexone; Organ Size; Pregnancy; Radiation Injuries, Experimental; Rats; Rats, Inbred Strains | 1987 |
Is the motivational effect of opiate withdrawal reflected by common somatic indices of precipitated withdrawal? A place conditioning study in the rat.
Topics: Animals; Avoidance Learning; Behavior, Animal; Body Weight; Dose-Response Relationship, Drug; Drug Implants; Male; Morphine; Motivation; Naltrexone; Quaternary Ammonium Compounds; Rats; Rats, Inbred Strains; Substance Withdrawal Syndrome | 1987 |
Opioid antagonist (naltrexone) modulation of cerebellar development: histological and morphometric studies.
Topics: Animals; Animals, Newborn; Body Weight; Cerebellum; Endorphins; Granulocytes; Naltrexone; Purkinje Cells; Rats; Rats, Inbred Strains | 1986 |
Endogenous analgesia in the pregnant rat: an artifact of weight-dependent measures?
Topics: Animals; Body Weight; Endorphins; Female; Naloxone; Naltrexone; Pain; Postpartum Period; Pregnancy; Pregnancy, Animal; Rats; Rats, Inbred Strains; Sensory Thresholds | 1986 |
Effects of beta-funaltrexamine (beta-FNA) on morphine dependence in rats and monkeys.
Topics: Animals; Body Weight; Dose-Response Relationship, Drug; Macaca mulatta; Male; Morphine Dependence; Naltrexone; Narcotic Antagonists; Rats; Rats, Inbred Strains; Species Specificity; Substance Withdrawal Syndrome; Time Factors | 1986 |
Effects of morphine, naltrexone, and dextrorphan in untreated and morphine-treated pigeons.
Topics: Animals; Behavior, Animal; Body Weight; Columbidae; Conditioning, Operant; Dextrorphan; Dose-Response Relationship, Drug; Drug Tolerance; Morphinans; Morphine; Naloxone; Naltrexone; Stereoisomerism | 1985 |
Naltrexone's influence on neurobehavioral development.
Topics: Animals; Behavior, Animal; Body Weight; Female; Male; Motor Activity; Naloxone; Naltrexone; Nervous System; Nociceptors; Psychomotor Performance; Rats; Rats, Inbred Strains; Reflex; Time Factors; Weaning | 1985 |
Discriminative stimulus effects of morphine withdrawal in the dependent rat: suppression by opiate and nonopiate drugs.
Topics: Animals; Body Weight; Clonidine; Haloperidol; Humans; Male; Morphine Dependence; Naloxone; Naltrexone; Narcotics; Rats; Rats, Inbred Strains; Stereoisomerism; Substance Withdrawal Syndrome | 1985 |
Dexamethasone differentially alters naltrexone effects on vasopressin and oxytocin release during tail electroshock.
Topics: Animals; Body Weight; Dexamethasone; Electroshock; Hematocrit; Male; Naltrexone; Oxytocin; Pituitary Gland; Rats; Rats, Inbred Strains; Tail; Time Factors; Vasopressins | 1985 |